What is a Section 112 Rejection?
The three requirements in § 112, why the rejection is about your own document rather than the prior art, the Amgen enablement standard, and the fixes for each.
Definition
A Section 112 rejection is an examiner's finding that a claim fails one of the disclosure requirements of 35 U.S.C. § 112: the specification does not adequately describe the claimed invention (written description), does not teach a skilled person how to make and use it without undue experimentation (enablement), or the claim language itself is unclear (indefiniteness). Unlike § 102 and § 103, it concerns the application, not the prior art.
Key Facts
- § 112(a): Written description, enablement, and best mode; best mode is no longer a basis for invalidity in litigation but remains a filing requirement
- § 112(b): Definiteness; claims must particularly point out and distinctly claim the invention
- § 112(f): Means-plus-function claims are construed to cover the structures in the specification and their equivalents
- Enablement standard: Full scope of the claim must be enabled without undue experimentation, sharpened for genus claims by Amgen v. Sanofi (2023)
- Indefiniteness standard in litigation: Nautilus v. Biosig (2014) requires that claims inform a skilled person of the scope with reasonable certainty; examiners apply a stricter "unclear" standard during prosecution
- Cannot be fixed with new matter: A written description or enablement gap can only be cured with what the original filing already contains
The Three Requirements
Written description asks whether the specification shows the inventor possessed the claimed invention at filing. The rejection typically arrives when claims are amended or a continuation is filed with claims that reach beyond the original disclosure, or when a genus is claimed and only a few species were described.
Enablement asks whether a skilled person could make and use the full scope of the claim from the specification without undue experimentation. The Wands factors, including the breadth of the claims, the amount of guidance, the presence of working examples, and the predictability of the art, govern the analysis. After Amgen, a functional genus claim in the biological or chemical arts supported by a handful of examples is at serious risk.
Indefiniteness asks whether the claim's words have a clear meaning. Common triggers are terms of degree without a standard ("substantially," "about"), lack of antecedent basis ("the widget" with no earlier "a widget"), mixed statutory classes in one claim, and means-plus-function elements with no corresponding structure in the specification.
Fixing Each
- Written description: Point to the passages, figures, or examples that show possession of the claimed feature; if none exist, narrow the claim to what was described
- Enablement: Cite the working examples and guidance, submit a declaration on the level of skill and the routineness of the experimentation, or narrow the claim to the enabled scope
- Indefiniteness: Amend the language; fix antecedent basis; define terms of degree by reference to the specification; for § 112(f) elements, identify the corresponding structure or rewrite the element structurally
Drafting Defensively
Most § 112 problems are drafting problems discovered years later. Specifications that describe alternatives, ranges, and multiple embodiments support amendments and continuations; specifications that describe one prototype do not. ArcPrime's patent drafting review checks every claim term for antecedent basis and specification support before filing, and its invention disclosure capture prompts inventors for the variations that written description later depends on.
Frequently Asked Questions
Don't see the answer you're looking for?
Feel free to reach out to us for more info.
What is the difference between written description and enablement?
Written description asks whether the specification shows the inventor actually possessed the claimed invention at filing. Enablement asks whether the specification teaches a skilled person how to make and use the full scope of the claim without undue experimentation. A specification can enable something it does not describe, and describe something it does not enable, so they are examined separately.
What makes a patent claim indefinite?
Language that does not inform a skilled person of the claim's scope with reasonable certainty. Typical causes are terms of degree with no standard in the specification, lack of antecedent basis, claims that mix an apparatus with a method of using it, and means-plus-function elements with no corresponding structure disclosed.
What did Amgen v. Sanofi change about enablement?
The Supreme Court held in 2023 that a claim to a genus defined by function, such as antibodies that bind a particular target, must be enabled across its full scope; a few working examples plus an instruction to screen candidates is not enough. The decision raised the bar for broad functional claims in biotechnology and chemistry.
Can a Section 112 rejection be overcome by adding to the specification?
No. New matter cannot be added to an application after filing. A written description or enablement gap must be cured from what the original disclosure already contains, usually by narrowing the claim. New material can only be filed in a continuation-in-part, and claims relying on it get the later filing date.
What is a means-plus-function claim?
A claim element written as a means or step for performing a function, without reciting structure, under 35 U.S.C. § 112(f). It is construed to cover only the structures described in the specification for that function and their equivalents. If the specification discloses no corresponding structure, the claim is indefinite.
Power Every Patent Decision
With One Platform
See how ArcPrime connects your portfolio, workflows, and business context to help your team make better decisions across the patent lifecycle.